CapitolRadar tracks every publicly disclosed GEHC trade by US congress members and corporate insiders: 17 disclosed trades (12 buys, 5 sells) by 2 tracked traders, from 2023-01-11 to 2026-09-11. Updated daily from official filings.
Want a ping when Congress buys GEHC? Free email alerts on notable disclosed trades — plus a $100,000 fantasy portfolio to play along against three AI traders. Join free
GE HealthCare Technologies Inc. (GEHC) — Healthcare · Medical - Devices, market cap about $31.8B.
Cluster watch: 2 distinct tracked traders disclosed buying GEHC in the last 45 days: Ro Khanna, Grogan William K (officer: Chief Financial Officer).
CapitolRadar analysis
15 GEHC trades, concentrated in one disclosed trader
GE HealthCare Technologies Inc. (GEHC), in the Healthcare / Medical - Devices industry, has 15 tracked trades from January 11, 2023 through July 30, 2026. The activity consists of 11 buys and four sells, making purchases 73% of the recorded transactions. However, the entire sample comes from just one distinct trader, so the buy-heavy split does not represent broad congressional participation.
Ro Khanna accounts for all 11 tracked buys, with the latest dated July 30, 2026. Because only one trader appears in the dataset, repeated purchases increase the transaction count without increasing the number of independent participants. That concentration is an important limitation when interpreting the pattern.
7 active quarters show a recent run of purchases
The supplied quarterly breakdown lists four trades in 2026 Q3, all buys; two in 2026 Q2, both buys; and one in 2026 Q1, which was not a buy. Earlier activity includes three trades in 2023 Q4, with two buys; two in 2023 Q3, with one buy; one buy in 2023 Q2; and two trades in 2023 Q1, with one buy.
Accordingly, the four sells occurred in 2026 Q1, 2023 Q4, 2023 Q3 and 2023 Q1. The sample is small and unevenly distributed across the covered period, while the supplied quarter list contains no activity for 2024 or 2025.
6 additional tickers overlap with the same buyer
The GEHC buyer also purchased ADI, ARES, CARR, CSCO, EW and HON. Each overlap is attributed to one buyer—the same size as the full GEHC buyer sample—so these links show breadth in that individual’s disclosed activity rather than agreement among multiple traders.
Congressional transaction disclosures can be filed with a lag of up to 45 days, meaning public visibility may substantially trail the trade date. Disclosed transaction amounts are generally reported as ranges and should be treated as estimates; no amount ranges were provided in this dataset. Those reporting constraints, together with the single-trader sample, limit conclusions from the raw counts.
Analysis written from the tracked record on 2026-08-31; it is refreshed whenever the underlying numbers change.
Activity by quarter
| Quarter | Disclosed trades | Buys | Sells |
|---|---|---|---|
| 2026 Q3 | 5 | 5 | 0 |
| 2026 Q2 | 2 | 2 | 0 |
| 2026 Q1 | 1 | 0 | 1 |
| 2023 Q4 | 3 | 2 | 1 |
| 2023 Q3 | 2 | 1 | 1 |
| 2023 Q2 | 1 | 1 | 0 |
| 2023 Q1 | 3 | 1 | 2 |
Who is buying GEHC?
| Trader | Disclosed buys | Last buy | Grade |
|---|---|---|---|
| Ro Khanna | 12 | 2026-09-11 | — |
Disclosed trades in GEHC
| Date | Who | Type | Amount | 30d vs SPY |
|---|---|---|---|---|
| 2026-09-11 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2026-07-30 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2026-07-07 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2026-07-06 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2026-07-02 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2026-06-30 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2026-04-13 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2026-01-29 | Ro Khanna | sell | $1,001 - $15,000 | — |
| 2023-11-03 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2023-10-10 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2023-10-02 | Ro Khanna | sell | $1,001 - $15,000 | — |
| 2023-08-29 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2023-07-28 | Ro Khanna | sell | $1,001 - $15,000 | — |
| 2023-05-23 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2023-01-20 | Michael McCaul | sell | $100,001 - $250,000 | — |
| 2023-01-11 | Ro Khanna | sell | $1,001 - $15,000 | — |
| 2023-01-11 | Ro Khanna | buy | $1,001 - $15,000 | — |
CapitolRadar signal history
NEW PICK 2026-10-12
Rep. Ro Khanna disclosed a $1,001–$15,000 purchase of GE HealthCare stock, and the company’s CFO was another recent buyer. The panel passed mainly because Khanna has no verified trading history showing that his purchases outperform the S&P 500, so the signal remains unproven. A reliable backtest showing consistent outperformance from his past buys would have strengthened the case enough to change the verdict.
These buyers also bought
Other stocks the tracked buyers of GEHC disclosed buying in the last six months: LH (1) · MET (1) · NKE (1) · PG (1) · RHHBY (1) · STLD (1).
About GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc. is a global medical technology company that creates, manufactures, and markets a diverse range of medical devices, services, and integrated digital solutions. These offerings are designed to assist in the diagnosis, treatment, and ongoing monitoring of patients. The company boasts an extensive international presence, serving markets across the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, and Hong Kong, among other regions. Its operations are structured across four primary business divisions: Imaging, Ultrasound, Patient Care S…
Frequently asked questions
Which politicians bought GEHC most?
Ro Khanna leads with 12 disclosed buys.
How current is this page?
It re-renders from the tracked record on every view and new filings are ingested daily — but STOCK Act disclosures can lag the trade by up to 45 days, so the most recent weeks are always incomplete.
Get alerts when trades like these are disclosed. Free account: fantasy portfolio + email alerts. Premium: a 6-hour head start on every signal.
CapitolRadar tracks publicly disclosed trades (STOCK Act filings and SEC Form 4). Disclosures can lag the trade by up to 45 days. Backtests measure past disclosed buys against the S&P 500 and do not predict future results. Everything on this page is impersonal information for your own research — not investment advice.